hutch-med.com (HCM): Net earnings per share growth forecast for next year

Graphic logo of HUTCHMED Ltd (HCM)

HUTCHMED (China) Limited (HCM) is monetizing its global oncology portfolio, generating multi-year royalties from patents. Tracking the projected change in earnings per share for the coming year on GURU.Markets, we note that the current metric is 27.50. Collaborations with biopharma behemoths to mitigate risks ensure stability. However, threats of approval delays in the US and an active burn of operating capital remain.

Hutchison MediPharma (HCM): Expected net earnings per share growth next year from 07/04/2022 to 11/16/2026

Metric breakdowns and analytics for HUTCHMED Ltd (HCM)

Fundamental company valuation:HUTCHMED Ltd
Brand item of Hutchison MediPharma

HUTCHMED (China) Limited's status as an oncology innovator enables the company to scale revenue through international drug recognition, which directly impacts the calculation of expected earnings per share. This metric measures the analysts' consensus forecast for net income growth rates, reflecting cash flow stability and asset revaluation risks, as clearly demonstrated by the projected change in earnings per share for the coming year.

Direct competitors

INCY (incyte.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year nuvationbio.com (NUVB)|Net earnings per share growth forecast for next year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Inhibrx Biosciences Inc INBX|I-Mab - Net earnings per share growth forecast for next year|FENC - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year herontx.com|NVCT: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Coherus CHRS|Expected earnings per share growth for next year CRBP|Expected net earnings per share growth next year Cardiff Oncology CRDF|Expected earnings per share growth for next year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Expected earnings per share trend next year|Lixte Biotechnology - Expected earnings per share growth for next year|Projected earnings per share increase next year CTXR (Citius Pharma)|Cellectar - Earnings growth forecast for next year|Expected earnings per share trend next year BLRX (BioLineRx Corp)|CANF: Earnings growth forecast for next year|Expected net earnings per share growth next year Aprea (APRE)|Net earnings per share growth forecast for next year kaziatherapeutics.com|SLXN: Expected earnings per share trend next year|Earnings growth forecast for next year NCNA|Earnings growth forecast for next year Chimerix Inc (CMRX)|Net earnings per share growth forecast for next year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Net earnings per share change forecast for next year|KRON: Expected earnings per share growth for next year|Expected net earnings per share growth next year Kintara Therapeutics Inc|oncternal.com (ONCT) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PRTG (Portage Biotech Corp)